![](/img/cover-not-exists.png)
90-Days mortality rate in patients treated within the context of a phase-I trial: How should we identify patients who should not go on trial?
Hendrik-Tobias Arkenau, David Olmos, Joo Ern Ang, Jorge Barriuso, Vasilios Karavasilis, Sue Ashley, Johann de Bono, Ian Judson, Stan KayeVolume:
44
Year:
2008
Language:
english
Pages:
1541
DOI:
10.1016/j.ejca.2008.04.017
File:
PDF, 243 KB
english, 2008